Prognostic value of FDG uptake in early stage non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 5, 2008, Pages 819-823

  Hanin, François Xavier ^a   Lonneux, Max ^a   Cornet, Julien ^a   Noirhomme, Philippe ^a   Coulon, Corinne ^a   Distexhe, Julien ^a   Poncelet, Alain J ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Non small cell lung cancer; PET FDG; Prognosis; SUV; Thoracic surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BODY WEIGHT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 41949109465     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.02.005     Document Type: Article

References (22)

1. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Fidler V., Pruim J., and Groen H.J. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 343 4 (2000) 254-261
2. Birim O., Kappetein A.P., Stijnen T., and Bogers A.J. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 79 1 (2005) 375-382
3. Cerfolio R.J., Ojha B., Bryant A.S., Bass C.S., Bartalucci A.A., and Mountz J.M. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 76 3 (2003) 861-866
4. 18F]-2-fluoro-deoxy-d-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 125 4 (2004) 1413-1423
5. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34 4 (2007) 463-471
6. Hellwig D., Groschel A., Graeter T.P., Hellwig A.P., Nestle U., Schafers H.J., Sybrecht G.W., and Kirsch C.M. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33 1 (2006) 13-21
7. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., and Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 1 (2007) 1-8
8. Davies A., Tan C., Paschalides C., Barrington S.F., O'Doherty M., Utley M., and Treasure T. FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer 55 1 (2007) 75-78
9. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., and Rusch V. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 16 (2004) 3255-3260
10. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43 1 (2002) 39-45
11. Ohtsuka T., Nomori H., Watanabe K., Kaji M., Naruke T., Suemasu K., and Uno K. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer 107 10 (2006) 2468-2473
12. Eschmann S.M., Friedel G., Paulsen F., Reimold M., Hehr T., Budach W., Scheiderbauer J., Machulla H.J., Dittmann H., Vonthein R., and Bares R. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?. Eur J Nucl Med Mol Imaging 33 3 (2006) 263-269
13. Borst G.R., Belderbos J.S., Boellaard R., Comans E.F., De Jaeger K., Lammertsma A.A., and Lebesque J.V. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer 41 11 (2005) 1533-1541
14. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 6 (1997) 1710-1717
15. Lonneux M., Borbath I., Bol A., Coppens A., Sibomana M., Bausart R., Defrise M., Pauwels S., and Michel C. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 26 6 (1999) 591-598
16. Tisi G., Friedman P., Peters R., Pearso G., Carr D., Lee R., and Selawry O. The American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Resp Dis 127 (1983) 659-664
17. Hermanek P., and Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract 190 2 (1994) 115-123
18. Brambilla E., Travis W.D., Colby T.V., Corrin B., and Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 18 6 (2001) 1059-1068
19. Kleinbaum D. Survival analysis. A self-learning text, New York: Springer-Verlag, 1996;45-82.
20. Cerfolio R.J., Bryant A.S., Ohja B., and Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
21. Westerterp M., Pruim J., Oyen W., Hoekstra O., Paans A., Visser E., van Lanschot J., Sloof G., and Boellaard R. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 34 (2007) 392-404
22. Alam N., Darling G., Evans W.K., Mackay J.A., and Shepherd F.A. Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review. Crit Rev Oncol Hematol 58 (2006) 146-155